Skip to content
Search

Latest Stories

NHS England awards £8.5m FDP contract to KPMG

NHS England awards £8.5m FDP contract to KPMG

Controversy sparked in November 2023 when NHS England awarded a £330 million contract for the FDP to US spy tech company Palantir 

NHS England has awarded an £8.5 million contract to consultancy firm KPMG "for technical support and implementation services" to help Integrated Care Boards (ICB) and NHS trusts in England to implement the Federated Data Platform (FDP) software.

According to the contract details published on Friday 12 April, KPMG "will support the NHSE Data Services team to not only build the Federated Data Platform (FDP) capability, but enhance the Data Service functions, platforms and integrating services to support the transformation change."


During the contract, which will extend until 17 March 2026, Additionally, the consultancy firm will assist ICBs and trusts in implementing their individual federated platforms, which will in turn feed into the national model.

NHSE ignited controversy in November 2023 when it granted a £330 million FDP contract to the US spy tech company Palantir, with concerns raised regarding the opaque nature of the tender process and the security of patient medical records.

On 22 December, NHS England published a heavily redacted version of its 586-page contract with Palantir to operate the platform.

After facing legal action from the Good Law Project, NHSE announced in March that it would republish its patient data contracts with Palantir with reduced redactions.

The legal campaign group also challenged NHS England over the extensive redactions in its contract with the bio-tech company IQVIA, which was awarded a £28m deal to provide “privacy enhancing technology” for the platform.

The Federated Data Platform software will enable NHS organisations to bring together operational data currently stored in separate systems, such as the number of beds in a hospital, the size of waiting lists for elective care services, or the availability of medical supplies, to support staff to access the information they need in one safe and secure environment.

NHSE has said that the FDP “will make it easier for staff at NHS trusts and integrated care boards (on behalf of integrated care systems (ICS) to access the information they need, freeing up valuable time to reinvest in delivering the best care possible for patients.”

“In the future, it will also enable Trusts and ICSs to make better use of the information they hold, supporting them to work together to understand patterns, solve problems, and plan services for their local populations,” it said.

As announced by the health service earlier, the implementation of the FDP will occur in stages spanning the next three years, beginning the transition phase from March to July 2024, followed by the delivery phase from May 2024 to March 2027. Once the transition phase proves successful, it will be gradually rolled out to new trusts and ICBs.

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less